DAVID STEVEN PELLMAN, M.D.
Medical Practice at Binney St, Boston, MA

License number
Massachusetts 71923
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address 2
44 Binney St, Boston, MA 02115
3 Ellsworth Park, Cambridge, MA 02139
Phone
(617) 632-4918

Professional information

David Steven Pellman Photo 1

David Steven Pellman, Boston MA

Specialties:
Pediatrics, Pediatric Hematology-Oncology
Work:
Dana-Farber Cancer Institute
44 Binney St, Boston, MA 02115
Education:
University of Chicago (1986)


David Steven Pellman Photo 2

Dr. David Steven Pellman, Boston MA - MD (Doctor of Medicine)

Specialties:
Pediatrics
Address:
44 Binney St STE M621A, Boston 02115
(617) 632-4918 (Phone), (617) 632-4865 (Fax)
DANA FARBER CANCER INSTITUTE
450 Brookline Ave, Boston 02215
(617) 632-3000 (Phone)
Certifications:
Pediatrics, 2005
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
44 Binney St STE M621A, Boston 02115
DANA FARBER CANCER INSTITUTE
450 Brookline Ave, Boston 02215
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1986
Childrens Hospital
Chldns/Dana Farber Canc Inst


David Pellman Photo 3

Professor Of Pediatrics And Cell Biology At Dfci/Harvard Med

Location:
Greater Boston Area
Industry:
Medical Practice


David Steven S Pellman Photo 4

David Steven S Pellman, Boston MA

Specialties:
Pediatrician
Address:
44 Binney St, Boston, MA 02115
450 Brookline Ave, Boston, MA 02215
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine


David Pellman Photo 5

Methods Of Treating A Meiotic Kinesin Associated Disease

US Patent:
8629118, Jan 14, 2014
Filed:
May 28, 2009
Appl. No.:
12/994920
Inventors:
David Pellman - Boston MA, US
Assignee:
Dana-Farber Cancer Institute, Inc. - Boston MA
International Classification:
C07H 21/02, C07H 21/04, A61K 31/70, C12Q 1/68
US Classification:
514 44A, 536 231, 536 241, 536 245, 435375, 435377
Abstract:
The invention provides methods of treating a meiotic kinase-associated disease, preferably the meiotic kinase HSET, by administering an inhibitor of the meiotic kinase. Preferably, the disease is associated with the presence of supernumerary centrosomes, such as cancer. Methods of inhibiting the growth of a tumor cell by contacting the cell with an inhibitor of a meiotic kinase, preferably HSET, are also provided. Screening methods for identifying inhibitors of the meiotic kinase HSET are also provided. Methods of selecting subjects for treatment with an inhibitor of a meiotic kinase, such as HSET, are also provided.